Investigating how neutrophil extracellular traps affect inflammatory bowel disease
Official title: Role of neutrophil extracellular traps (NETs) in Inflammatory bowel disease
Funded at University of Toledo Health Sci Campus · NIH-11019711 · Data updated 2026-11-12
This study is looking at how a certain enzyme affects the immune response in people with inflammatory bowel disease (IBD), like Crohn's Disease and Ulcerative Colitis, to help find new ways to improve gut health and treatment options.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Toledo Health Sci Campus NIH-funded |
| Lab location | 1 site (Toledo, United States) |
| Project start | February 15, 2023 |
| Project end | January 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $430,127 |
| NIH project number | 5R01DK134053-03 |
| Project ID | NIH-11019711 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with inflammatory bowel disease, including Crohn’s Disease and Ulcerative Colitis.
✕Less likely to help
Patients with other gastrointestinal disorders not classified as inflammatory bowel disease may not benefit from this research.
What this research studies
This research focuses on understanding the role of neutrophil extracellular traps (NETs) in inflammatory bowel disease (IBD), which includes conditions like Crohn’s Disease and Ulcerative Colitis. The study will explore how a specific enzyme, peptidyl arginine deiminase-4 (PAD4), influences the release of NETs and their impact on gut health. By using murine models, the research aims to uncover the molecular mechanisms behind PAD4's role in inflammation and tissue repair in the gastrointestinal tract. Patients may benefit from insights that could lead to new therapeutic strategies for managing IBD.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve the management of inflammatory bowel disease.
How similar studies have gone: While the role of NETs in inflammation is being explored, this specific investigation into PAD4's function in IBD is relatively novel and has not been extensively tested.
Where this research is happening
-
University of Toledo Health Sci Campus
Toledo, United States Active
Researchers
- Principal investigator: Vijay-Kumar, Matam — University of Toledo Health Sci Campus
- Study coordinator: Vijay-Kumar, Matam
Related research
Other NIH-funded projects on the same topics.
-
Mitochondrial Talks: How Energy Networks Shape Inflammatory Bowel Disease
Aimed at people with inflammatory bowel disease (IBD), this project explores how tiny cell powerhouses in the gut may go out of balance and contribute to IBD, with the goal of restoring energy and reducing disease symptoms.
-
Mn in inflammatory bowel disease: how manganese and genes may shape gut inflammation
This grant studies how the mineral manganese and a specific gene variant may influence inflammatory bowel disease in people of different ages.
-
AI-Enhanced Virtual Reality CBT to Reduce Anxiety for IBD Patients
A home-based VR and AI-powered cognitive behavioral therapy program is being tested to help people with inflammatory bowel disease feel less anxious and improve their quality of life.
-
Gasdermin-based epithelial function in inflammatory bowel disease
A funding opportunity that explores how gasdermin proteins affect the lining of the gut and may influence inflammatory bowel disease.
-
Intestinal chondroitin sulfate glycosaminoglycans and their role in inflammatory bowel disease
A clinician-scientist mentoring program aims to advance understanding of how intestinal sugar molecules called chondroitin sulfate glycosaminoglycans influence inflammatory bowel disease and patient care.
-
Improving IBD outcomes through community awareness, referrals, and education
A U01 grant will support programs to raise awareness, improve referrals, and educate patients and clinicians about inflammatory bowel disease to improve diagnosis and care.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.